XFOR
X4 Pharmaceuticals, Inc. · Healthcare
Chief Financial Officer David Kirske sold $36K of X4 Pharmaceuticals, Inc.
Sold$36,428
$4.26Price
8,543Shares
−5%Stake
What XFOR did after the filing
- The stock from Thu, Jul 2 open, $4.15
- +1.7%
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Aug 14 close.
Traded Tue, Jun 30. Filed Wed, Jul 1, 4:23 PM ET, after the close. Returns use the Jul 2 open and the Aug 14 close. Not investment advice.